{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:03:13Z","timestamp":1790229793103,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite the availability of a safe and effective Human Papillomavirus (HPV) vaccine, uptake remains inconsistent across the United States (U.S.), with marked differences in vaccination coverage across states. This descriptive exploratory study examined key informant perspectives on HPV vaccination promotion across policy-engaged jurisdictions in the U.S. in the post-COVID-19 era.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews were conducted with nine key informants across six U.S. jurisdictions. Classification of the interviews was based on those with existing HPV vaccine school-entry requirements or those jurisdictions with recent school-entry policy considerations. Using inductive thematic analysis, we synthesized key informant perspectives and organized themes using analytical dimensions informed by the socio-ecological model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Findings highlight the importance of provider education, school-entry requirements, cancer prevention messaging, trusted messengers, culturally tailored outreach, and cross-sector partnerships as important components of HPV vaccine promotion. Barriers such as vaccine misinformation and increased hesitancy following the COVID-19 pandemic were also discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These insights can inform targeted, context-specific strategies to improve HPV vaccination rates and reduce cancer disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1810928","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:44:21Z","timestamp":1790228661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Context-specific strategies for enhancing HPV vaccination: key informant perspectives from selected U.S. jurisdictions in the post-COVID-19 era"],"prefix":"10.3389","volume":"14","author":[{"given":"Erika","family":"Escab\u00ed-Wojna","sequence":"first","affiliation":[{"name":"Department of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"\u00c1lamo-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Acosta-Rull\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"V\u00e9lez-Crespo","sequence":"additional","affiliation":[{"name":"Center for Tropical Diversity, Puerto Rico Science, Technology & Research Trust","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Col\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref1","year":"2024"},{"key":"ref2","year":"2024"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination coverage among adolescents aged 13\u201317 years \u2014 National Immunization Survey-Teen, United States, 2024","volume":"74","author":"Pingali","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/21645515.2019.1627817","article-title":"State statutes and regulations related to human papillomavirus vaccination","volume":"15","author":"Hoss","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"210035","DOI":"10.5888\/pcd18.210035","article-title":"HPV vaccine school entry requirement in Puerto Rico: historical context, challenges, and opportunities","volume":"18","author":"Col\u00f3n-L\u00f3pez","year":"2021","journal-title":"Prev Chronic Dis"},{"key":"ref6","year":"2024"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"126425","DOI":"10.1016\/j.vaccine.2024.126425","article-title":"Enhancing HPV vaccine uptake in girls and boys \u2013 a qualitative analysis of Canadian school-based vaccination programs","volume":"42","author":"Dub\u00e9","year":"2024","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1080\/21645515.2020.1839290","article-title":"Influences on HPV vaccination across levels of the social ecological model: perspectives from state level stakeholders","volume":"17","author":"Ryan","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pvr.2017.11.003","article-title":"Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action","volume":"5","author":"Cartmell","year":"2018","journal-title":"Papillomavirus Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10552-020-01323-y","article-title":"Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review","volume":"31","author":"Peterson","year":"2020","journal-title":"Cancer Causes Control"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2550054","article-title":"Provider perspectives on HPV vaccine hesitancy in the post-COVID-19 era","volume":"21","author":"Hoang","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"pkac053","DOI":"10.1093\/jncics\/pkac053","article-title":"HPV vaccination uptake, hesitancy, and refusal: observations of health-care professionals during the COVID-19 pandemic","volume":"6","author":"Chido-Amajuoyi","year":"2022","journal-title":"JNCI Cancer Spectr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MOP.0000000000001441","article-title":"HPV vaccine hesitancy in the United States","volume":"37","author":"Joshi","year":"2025","journal-title":"Curr Opin Pediatr"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4135\/9781483384436","volume-title":"Applied Thematic Analysis","author":"Guest","year":"2012"},{"key":"ref15","year":"2025"},{"key":"ref16","author":"Brandt","year":"2023"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e20161764","DOI":"10.1542\/peds.2016-1764","article-title":"Announcements versus conversations to improve HPV vaccination coverage: a randomized trial","volume":"139","author":"Brewer","year":"2017","journal-title":"Pediatrics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2022.2058264","article-title":"Key stakeholder perspectives on challenges and opportunities for rural HPV vaccination in north and South Carolina","volume":"18","author":"Fish","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0033354920954512","article-title":"A mixed-methods analysis of barriers to and facilitators of human papillomavirus vaccination among adolescents in Montana","volume":"135","author":"Newcomer","year":"2020","journal-title":"Public Health Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12885-024-12351-1","article-title":"Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia","volume":"24","author":"Petagna","year":"2024","journal-title":"BMC Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pvr.2016.12.003","article-title":"Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: a qualitative study in Alabama","volume":"3","author":"Westrick","year":"2017","journal-title":"Papillomavirus Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ypmed.2018.05.021","article-title":"The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama","volume":"113","author":"Dilley","year":"2018","journal-title":"Prev Med (Baltim)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/phn.12044","article-title":"Health care providers\u2019 perspectives on low HPV vaccine uptake and adherence in Appalachian Kentucky","volume":"30","author":"Head","year":"2013","journal-title":"Public Health Nurs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2105\/AJPH.2017.304263","article-title":"A qualitative comparative analysis of combined state health policies related to human papillomavirus vaccine uptake in the United States","volume":"108","author":"Roberts","year":"2018","journal-title":"Am J Public Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0000782","DOI":"10.1371\/journal.pgph.0000782","article-title":"Human papillomavirus vaccine initiation and up-to-date vaccine coverage for adolescents after the implementation of school-entry policy in Puerto Rico","volume":"2","author":"Col\u00f3n-L\u00f3pez","year":"2022","journal-title":"PLOS Global Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/vaccines11081359","article-title":"Attitudes towards HPV vaccination policy strategies to improve adolescent vaccination coverage among pediatric providers in New York state","volume":"11","author":"Shaw","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2023064692","DOI":"10.1542\/peds.2023-064692","article-title":"Policy approaches for increasing adolescent HPV vaccination coverage: a systematic review","volume":"153","author":"McKeithen","year":"2024","journal-title":"Pediatrics"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1810928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:44:22Z","timestamp":1790228662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1810928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":27,"alternative-id":["10.3389\/fpubh.2026.1810928"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1810928","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1810928"}}